8-Hydroxy-2-desoxyguanosine serum concentrations as a marker of DNA damage in patients with classical galactosaemia

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 2, 2006, Pages 164-169

  Schulpis, Kleopatra H ^a   Papassotiriou, Ioannis ^a   Tsakiris, Stylianos ^b  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

8 OhdG; Free radicals; Galactosaemia; Galactose 1 phosphate

Indexed keywords

8 HYDROXY 2 DESOXYGUANOSINE; BIOLOGICAL MARKER; DNA; GALACTOSE 1 PHOSPHATE; GUANOSINE DERIVATIVE; PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DNA DAMAGE; GALACTOSEMIA; HUMAN; IMMUNOASSAY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SPECTROPHOTOMETRY; VENOUS BLOOD;

ANTIBODIES, MONOCLONAL; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHILD; DEOXYADENOSINES; DNA DAMAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREE RADICALS; GALACTOSEMIAS; HUMANS; OXIDATIVE STRESS; SPECTROPHOTOMETRY;

EID: 31944443477     PISSN: 08035253     EISSN: 15023869     Source Type: Journal    
DOI: 10.1080/08035250500297810     Document Type: Article

References (36)

1. Waggoner DD, Buist NMR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inher Metab Dis 1990;13:802-18.
2. Holton JB. Galactosaemia: pathogenesis and treatment. J Inher Metab Dis 1996;19:3-7.
3. Berry GT, Nissim I, Lin Z, Mazur AT, Gibson JB, Segal S. Evidence for endogenous synthesis of galactose in normal man and patients with galactosaemia. Lancet 1995;346:1073-4.
4. Schulpis KH, Papaconstantinou ED, Michelakakis H, Shin Y. Screening for galactosaemia in Greece. Pediatr Perinatal Epidemiol 1997;11:436-40.
5. Palmieri M, Mazur A, Berry GT. Urine and plasma galactitol in patients with galactose-1-phosphate uridyltranserase deficiency galactosaemia. Metabolism 1999;48:1294-302.
6. Berry GT, Segal S. Disorder of galactose metabolism. In: Scriver CR, Beadet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disorders. New York: McGraw Hill; 2001. p. 1553-89.
7. Wajner M, Latini A, Wyse AT, Dutra-Filho CS. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 2004;27:427-48.
8. Schulpis KH, Karikas GA, Kokotos G. Direct molecular interaction of phenylalanine with DNA measured by reversed phase HPLC. Clin Chem 1998;48:178-9.
9. Finker T, Holbrook NJ. Oxidants, oxidative stress and the biology of aging. Nature 2000;408:239-47.
10. Yaki K. Lipid peroxides and related radicals in clinical medicine. In: Armstrong D, editor. Free radicals in diagnostic medicine. New York: Plenum Press; 1994. p. 1-14.
11. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA in extensive. Proc Natl Acad Sci U S A 1988;85:6565-7.
12. Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A, Tonooka H. Formation of 8-hydroxyguanine moiety in cellular DNA by agents production oxygen radicals and evidence for its repair. Carcinogenesis 1986;7:1849-51.
13. Kasai H, Nishimura S, Kurokawa Y, Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8- hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 1987;8:1959-61.
14. Yin B, Whyatt RM, Perera FP, Randal MC, Cooper TB, Santella RM. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody based ELISA. Free Radic Biol Med 1995;18:1023-32.
15. +-ATPase inhibition by free radicals. Z Naturforsch 2000;55c: 271-7.
16. +-ATPase activity. Z Naturforsch 2002;57c:939-43.
17. 2+-ATPase activities induced by the in vitro galactosaemia. Pharmacol Res 2004;49:475-9.
18. Francis D. Diets for sick children, 4th ed. Oxford: Blackwell; 1987. p. 335-48.
19. Orfanos AP, Jinks DC, Guthrie R. Microassay for estimation of galactose and galactose-1-phosphate in dried blood specimens. Clin Biochem 1986;19:225-8.
20. Miller NJ, Rice-Evans C, Davies MJ, Copinathan V, Milner A. A novel method for measuring antioxidant capacity and application to monitoring the antioxidant status in premature neonates. Clin Soc (Colch) 1993;84:407-12.
21. Strube M, Haenen GR, Van den Berg H, Bast A. Pit falls in a method for measurement of total antioxidant capacity. Free Radic Res 1997;26:315-21.
22. Kanofsky JR, Hoogland H, Wever R, Weiss SJ. Singlet oxygen production by human eosinophils. J Biol Chem 1988;263:9692-6.
23. Steinberg D, Partharathy S, Carew TE, Khoo JC, Witztum MD. Beyond cholesterol modifications of low density lipoprotein that increase atherogenicity. N Engl J Med 1989;320:915-24.
24. Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year . A historical book in the future. Ann N Y Acad Sci ;899 2000;2000:136-47.
25. Gotz ME, Kunig G, Riederer P, Youdim MBH. Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 1994;63:37-122.
26. Beckman B, Amer BW. Oxydative decay of DNA. J Biol Chem 1997;272:19633-9.
27. Gitzelman R. Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr 1995;154 Suppl 2:S45-9.
28. Gilbert DL. Fifty years of radical ideas. Ann N Y Acad Sci 2000;899:1-20.
29. Iguarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 1999;34:879-83.
30. Rock E, Astier C, Lab C. Dietary magnesium deficiency in rats enhances free radical production in skeletal muscle. J Nutr 1995;128:1205-9.
31. Duprat F, Guillemare E, Romey G, Fink M, Lesage F, Lazdunski M, et al. Susceptibility of cloned K+ channels to reactive oxygen species. Proc Natl Acad Sci U S A 1995;92:11796-800.
32. McConnell EJ, Bittelmeyer AM, Raess BU. Irreversible inhibition of plasma membrane (Ca2++Mg2+)-ATPase and Ca2+ transport by 4-OH-2,3-trans-nonenal. Arch Biochem Biophys 1999;361:252-6.
33. 2+ -ATPase activities in patients with classical galactosaemia. Clinical Nutrition, in press.
34. Ning C, Reynolds R, Chen J, Yaker C, Berry JT, McNamara PD, et al. Galactose metabolism by the mouse with galactose-1-phosphate uridyl transferase deficiency. Pediatr Res 2000;48:211-7.
35. Bogdanov M, Brown RH, Matson W, Smart R, Hayden D, O'Donnel H, et al. Increased oxidative damage to DNA in ALS patients. Free Radical Biol Nad Med 2000;29:652-8.
36. Galaris D, Evangelou A. The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit Rev Oncol Haematol 2002;42:93-103.